Jurjen van der Schans

Latest

• Comments on A Conceptual Framework for Life-Cycle Health Technology Assessment
• Recombinant Zoster Vaccine for High-Risk Ageing Adults in the Netherlands Cost-Effectiveness and Value of Information Analyses